A link to the Copyright Permissions Request Form appears on the right side of the page. 2014 AHA/ACC Guideline for the Management of Patients With Non ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the Society for Cardiovascular Angiography and Interventions and Society of Thoracic Surgeons Endorsed by the American Association for Clinical Chemistry WRITING COMMITTEE MEMBERS* Ezra A. Amsterdam, MD, FACC, Chair ; Nanette K. Wenger, MD, MACC, FAHA, Vice Chair* ; Ralph G. Brindis, MD, MPH, MACC, FSCAI ; Donald E. Casey Jr, MD, MPH, MBA, FACP, FAHA ; Theodore G. Ganiats, MD ; David R. Holmes Jr, MD, MACC ; Allan S. Jaffe, MD, FACC, FAHA* ; Hani Jneid, MD, FACC, FAHA, FSCAI ; Rosemary F. Kelly, MD ; Michael C. Kontos, MD, FACC, FAHA* ; Glenn N. Levine, MD, FACC, FAHA ; Philip R. Liebson, MD, FACC, FAHA ; Debabrata Mukherjee, MD, FACC ; Eric D. Peterson, MD, MPH, FACC, FAHA*#; Marc S. Sabatine, MD, MPH, FACC, FAHA* ; Richard W. Smalling, MD, PhD, FACC, FSCAI***; Susan J. Zieman, MD, PhD, FACC Amsterdam et al 2014 AHA/ACC NSTE-ACS Guideline e345 Table of Contents Preamble e346 1. Introduction e347 1.1. Methodology and Evidence Review e347 1.2. Organization of the GWC e348 1.3. Document Review and Approval e349 1.4. Scope of the CPG e349 2. Overview of Acs e349 2.1. Definition of Terms e349 2.2. Epidemiology and Pathogenesis e349 2.2.1. Epidemiology e349 2.2.2. Pathogenesis e350 3. Initial Evaluation and Management e350 Clinical Assessment and Initial Evaluation: Recommendation e350 ED or Outpatient Facility Presentation: Recommendations e352 3.2. Diagnosis of NSTE-ACS e352 3.2.1. History e352 3.2.2. Physical Examination e352 3.2.3. Electrocardiogram e353 Biomarkers of Myocardial Necrosis e353 3.2.5. 